Tech Company Financing Transactions
Glooko Funding Round
Glooko, operating out of Palo Alto, secured $30 million from Health Catalyst Capital Management, Canaan Partners and Georgian.
Transaction Overview
Company Name
Announced On
3/17/2021
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
Health Catalyst Capital Management (Lead Investor) (Charles Boorady)
Canaan Partners (Wende Hutton)
Proceeds Purpose
Proceeds will be used to accelerate organic growth and strategic initiatives across the company's broad and growing product line of advanced digital health solutions.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
411 High St.
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
Glooko enhances the way diabetics and their care providers interact by leveraging the power of mobile, cloud, and analytics to transform diabetes management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russ Johannesson
Chief Financial Officer
Stephen Lien
Chief Medical Officer
Mark Clements
Chief Operating Officer
Komathi Stem
Chief Technical Officer
Kyle Brown
Executive Vice President
David Conn
Founder
Yogen Dalal
General Manager
Anders Sonesson
VP - Bus. Development
Zach Henderson
Browse more venture capital transactions:
Prev: 3/17/2021: SafeGraph venture capital transaction
Next: 3/17/2021: Noogata venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs